| Market Size in 2024 | Market Forecast in 2034 | CAGR (in %) | Base Year |
|---|---|---|---|
| USD 34.86 Million | USD 340.49 Million | 25.60% | 2024 |
FrequentlyAsked Questions
Non-invasive blood glucose monitoring devices are healthcare equipment that monitor blood sugar levels without using a needle or the finger-pricking method.
The global non-invasive blood glucose monitoring devices market is expected to grow due to the rising number of diabetic patients across the globe.
According to study, the global non invasive blood glucose monitoring devices market size was worth around USD 34.86 million in 2024 and is predicted to grow to around USD 340.49 million by 2034.
The CAGR value of the non-invasive blood glucose monitoring devices market is expected to be around 25.60% during 2025-2034.
The global non-invasive blood glucose monitoring devices market will be led by North America during the forecast period.
The global non invasive blood glucose monitoring devices market is led by players like Integrity Applications, Abbott Laboratories, Roche Diagnostics, Know Labs Inc., Occuity Ltd., LifePlus Inc., Medtronic Plc, Meta Materials Inc., Afon Technology Ltd., Dexcom Inc., BLUESEMI, Nemaura Medical, Cnoga Medical, DiaMonTech GmbH, and NovioSense BV.
The report explores crucial aspects of the non invasive blood glucose monitoring devices market, including a detailed discussion of existing growth factors and restraints, while also browsing future growth opportunities and challenges that impact the market.
HappyClients